NO_LONGER_AVAILABLENCT03433131

Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy

Studying Narcolepsy

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Harmony Biosciences Management, Inc.
Principal Investigator: Michael Thorpy, MD
Albert Einstein College of Medicine
Intervention: Pitolisant(drug)
Eligibility: 18 years · All sexes

Study locations (30)

Sleep Disorders Center of Alabama, Birmingham, Alabama, United States
CPC, Cullman, Alabama, United States
Xenoscience, Phoenix, Arizona, United States
Foothills Neurology, Phoenix, Arizona, United States
Mayo Clinic, Scottsdale, Arizona, United States
Sleep Medicine Specialists of California, San Ramon, California, United States
Santa Monica Sleep Disorders Center, Santa Monica, California, United States
Children's Hospital Colorado, Aurora, Colorado, United States
Colorado Sleep Institute, Boulder, Colorado, United States
Norwalk Hospital Sleep Disorders Center, Norwalk, Connecticut, United States
Clinical Neurosciences fo Tampa Bay, Clearwater, Florida, United States
Mayo Clinic, Jacksonville, Florida, United States
Sleep Medicine Specialists of South Florida, PA, Miami, Florida, United States
Child Lung, Asthma Sleep Specialists, Winter Park, Florida, United States
Emory University, Atlanta, Georgia, United States
+15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03433131 on ClinicalTrials.gov

Other trials for Narcolepsy

Additional recruiting or active studies for the same condition.

See all trials for Narcolepsy →

← Back to all trials